Your browser doesn't support javascript.
Post-acute COVID-19 condition in Saudi Arabia: A national representative study.
AlRadini, Faten A; Alamri, Fahad; Aljahany, Muna S; Almuzaini, Yasir; Alsofayan, Yousef; Khan, Anas; Albogami, Nada; Abdulrahim, Maha; Almogbil, Alanoud; Alahmari, Ahmed.
  • AlRadini FA; Department of Clinical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia. Electronic address: faalradini@pnu.edu.sa.
  • Alamri F; Global Center of Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia, Family Medicine, Primary Health Center, Riyadh, Saudi Arabia. Electronic address: fahadamri@yahoo.com.
  • Aljahany MS; Department of Clinical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia. Electronic address: msaljahany@pnu.edu.sa.
  • Almuzaini Y; Global Center of Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia. Electronic address: almuzaini.yasir1@gmail.com.
  • Alsofayan Y; General Directorate of Data and Research, Saudi Red Crescent Authority, Riyadh, Saudi Arabia. Electronic address: y-m-alsofayan@hotmail.com.
  • Khan A; Global Center of Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia; Department of Emergency Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Electronic address: anaskhan@ksu.edu.sa.
  • Albogami N; Department of Psychiatry Medicine, National Security Hospital, Riyadh, Saudi Arabia. Electronic address: dralbogami@gmail.com.
  • Abdulrahim M; Research and Academic Accreditation Office, King Abdullah Bin Abdulaziz University Hospital, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia. Electronic address: mabdulrahim@kaauh.edu.sa.
  • Almogbil A; Research Unit, Researcher-Freelancer, Riyadh, Saudi Arabia. Electronic address: Alanoud.almogbel@outlook.com.
  • Alahmari A; Global Center of Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia. Electronic address: ahalalahmari@moh.gov.sa.
J Infect Public Health ; 15(5): 526-532, 2022 May.
Article in English | MEDLINE | ID: covidwho-1814758
ABSTRACT

BACKGROUND:

Many survivors of COVID-19 have developed symptoms and diseases similar to those observed after severe acute respiratory syndrome (SARS). Therefore, this study aimed to characterize the symptoms that appear after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been eradicated and to determine their relationship with COVID-19 severity.

METHODS:

This multicenter, retrospective cross-sectional study was conducted in all eligible confirmed cases of SARS-CoV-2 infection from Saudi Arabia. Study participants were randomly selected using computerized random sampling from a population of 314,821 patients. Descriptive statistics were used to describe baseline demographic data and clinical characteristics. Categorical variables were presented as counts and percentages, while continuous variables were presented as means and standard deviations.

RESULTS:

Approximately 70% of patients were found to have five or fewer symptoms simultaneously. Late symptoms (in the ongoing symptomatic COVID-19) occurred in 225 (22·5%) patients with the most common late symptoms being loss of smell, loss of taste, fatigue, shortness of breath, and cough (52·4%, 31·1%, 11·5%, 10·2%, and 8·9% of patients with late symptoms, respectively). We also found that the presence of acute symptoms of COVID-19 and admission to the hospital were significant independent predictors of the post-COVID-19 condition.

CONCLUSION:

Saudi patients with COVID-19 develop a wide range of symptoms, similar to those observed and reported in other countries. The loss of smell, the loss of taste, shortness of breath, and fatigue were the main persistent symptoms. Regular follow-up of COVID-19 survivors is highly recommended to minimize the burden of the post-acute COVID-19 condition and improve the quality of life of patients.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ageusia / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: J Infect Public Health Journal subject: Communicable Diseases / Public Health Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Ageusia / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: J Infect Public Health Journal subject: Communicable Diseases / Public Health Year: 2022 Document Type: Article